Testicular cancer in Australia statistics

New cases

In 2021, there were 887 new cases of testicular cancer diagnosed in Australia. In 2025, it is estimated that 1,040 new cases of testicular cancer will be diagnosed in Australia. In 2025, it is estimated that a male has a 1 in 188 (or 0.53%) risk of being diagnosed with testicular cancer by the age of 85.

In 2021, the age-standardised incidence rate was 7.0 cases per 100,000 males. In 2025, it is estimated that the age-standardised incidence rate will be 7.5 cases per 100,000 males. The incidence rate for testicular cancer is expected to be highest among men aged 30–34 years.

The number of new cases of testicular cancer diagnosed increased from 321 in 1982 to 887 in 2021. Over the same period, the age-standardised incidence rate increased from 4.1 cases per 100,000 males in 1982 to 7.0 cases per 100,000 males in 2021.

Deaths 

In 2023, there were 29 deaths from testicular cancer in Australia. In 2025, it is estimated that there will be 37 deaths. In 2025, it is estimated that a male had a 1 in 4,635 (or 0.02%) risk of dying from testicular cancer by the age of 85.

In 2023, the age-standardised mortality rate was 0.2 deaths per 100,000 males. In 2025, it is estimated that the age-standardised mortality rate will be 0.3 deaths per 100,000 males. The mortality rate for testicular cancer is expected to vary across age groups.

The number of deaths from testicular cancer decreased from 34 in 1982 to 29 in 2023. Over the same period, the age-standardised mortality rate decreased from 0.5 deaths per 100,000 males in 1982 to 0.2 deaths per 100,000 males in 2023. 

Survival 

In 2017–2021, individuals diagnosed with testicular cancer had a 98% chance of surviving for five years compared to their counterparts in the general Australian population. Between 1987–1991 and 2017–2021, five-year relative survival for testicular cancer increased from 95% to 98%.

Prevalence 

At the end of 2021, there were 873 people living who had been diagnosed with testicular cancer that year, 4,398 people living who had been diagnosed with testicular cancer in the previous 5 years (from 2017 to 2021) and 21,648 people living who had been diagnosed with testicular cancer in the previous 40 years (from 1982 to 2021).

For more information on cancer data, see the NCCI website

The National Cancer Control Indicators (NCCI) are a set of indicators across the continuum of cancer care, from Prevention and Screening through to Diagnosis, Treatment, Psychosocial care, Research and Outcomes.  The NCCI website allows users to see visual representations of data on each indicator through interactive charts.